ADXN
Addex Therapeutics LtdNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$7.44M
P/E Ratio
—
EPS
$-9.02
Beta
1.86
52W High
$12.05
52W Low
$5.57
50-Day MA
$7.12
200-Day MA
$8.18
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Addex Therapeutics Ltd
Addex Therapeutics Ltd, a developing-stage biopharmaceutical company, discovers, develops and markets small molecule pharmaceuticals for central nervous system (CNS) disorders in Switzerland. The company is headquartered in Geneva, Switzerland.
Fundamentals
| Revenue (TTM) | 158,540 |
| Gross Profit (TTM) | -525,653 |
| EBITDA | $-2.46M |
| Operating Margin | -1404.00% |
| Return on Equity | -72.80% |
| Return on Assets | -15.90% |
| Revenue/Share (TTM) | $0.24 |
| Book Value | $0.06 |
| Price-to-Book | 0.94 |
| Price-to-Sales (TTM) | 46.94 |
| EV/Revenue | 133.52 |
| EV/EBITDA | -0.76 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -15.00% |
| Shares Outstanding | $1.23M |
| Float | $92.72M |
| % Insiders | 0.00% |
| % Institutions | 0.06% |
Data last updated: 4/7/2026